These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27203818)

  • 21. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia.
    Mowitz ME; Mangili A; Han L; Ayyagari R; Gao W; Wang J; Zhao J; Sarda SP
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1117-1125. PubMed ID: 33236680
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia.
    Han YM; Seo HJ; Choi SH; Jung YJ; Ahn SY; Yoo HS; Sung SI; Shim JW; Lee YK; Ko SY; Shin SM; Hwang JH; Lee JH; Choi BM; Kim ES; Jeon JH; Kim SS; Chang YS; Park WS
    J Korean Med Sci; 2015 Jul; 30(7):924-31. PubMed ID: 26130956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan.
    Chi H; Chung CH; Lin YJ; Lin CH
    PLoS One; 2018; 13(5):e0197410. PubMed ID: 29746578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    Chaw PS; Hua L; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S620-S627. PubMed ID: 31825072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Medical Resources by Preterm Infants Born at Less than 33 Weeks' Gestation Following Discharge from the Neonatal Intensive Care Unit in Korea.
    Lee JH; Chang YS;
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S95-S103. PubMed ID: 26566364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and severity of acute respiratory infections during the first year among very preterm infants: an Epipage-2 cohort analysis.
    Charkaluk ML; Rousseau J; Dehouck-Vallois M; Jarreau PH; Nuytten A; Treluyer L; Ancel PY; Torchin H
    Eur J Pediatr; 2021 Jun; 180(6):1833-1840. PubMed ID: 33527179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
    Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden, Etiology, and Risk Factors of Respiratory Virus Infections Among Symptomatic Preterm Infants in the Tropics: A Retrospective Single-Center Cohort Study.
    Yeo KT; de la Puerta R; Tee NWS; Thoon KC; Rajadurai VS; Yung CF
    Clin Infect Dis; 2018 Oct; 67(10):1603-1609. PubMed ID: 29659748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.
    Oncel MY; Mutlu B; Kavurt S; Baş AY; Demirel N; Akyol M; Erdeve O; Dilmen U
    Turk J Pediatr; 2012; 54(4):344-51. PubMed ID: 23692714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.
    Smith VC; Zupancic JA; McCormick MC; Croen LA; Greene J; Escobar GJ; Richardson DK
    J Pediatr; 2004 Jun; 144(6):799-803. PubMed ID: 15192629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory syncytial virus bronchiolitis in ex-preterm infants in the Scottish highlands: review of hospital admissions and an analysis of hospital cost.
    Zaw W; McDonald J
    Scott Med J; 2003 Nov; 48(4):108-10. PubMed ID: 14702843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation.
    Flamant C; Hallalel F; Nolent P; Chevalier JY; Renolleau S
    Eur J Pediatr; 2005 Feb; 164(2):93-8. PubMed ID: 15703980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis.
    Carpenter TC; Stenmark KR
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S33-40. PubMed ID: 14730268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term respiratory outcomes of very premature birth (<32 weeks).
    Greenough A
    Semin Fetal Neonatal Med; 2012 Apr; 17(2):73-6. PubMed ID: 22300711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.